iShares Short-Term California Muni Active ETF CALI 深 沪
已收盘 08-22 16:00:00 美东时间
50.59
+0.050
+0.10%
华盛通- 最 高50.5986
- 今 开50.58
- 成交量 2.77万股
- 最 低 50.564
- 昨 收 50.54
- 总市值 1.11亿
- 52周最高 50.64
- 市盈率 静 --
- 换手率 1.26%
- 52周最低 -1.0052
- 委 比 95.03%
- 总股本 220.00万
- 历史最高 50.64
- 量 比 0.82
- 振 幅 0.07%
- 历史最低 -2.8442
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ainos Launches Patented AI Nose Platform For Industrial And Healthcare Markets, Unveils SmellTech-As-A-Service At Automation Taipei 2025
Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments UnderwaySmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead
08-14 21:39
Caliber Sets Date for Second Quarter 2025 Earnings Announcement & Investor Conference Call
Caliber announced it will release its Q2 2025 financial results on August 13 after market close, with a webcast/conference call at 5:00 pm ET the same day. Investors can join via phone or the company’s website. Caliber, with $2.9 billion in managed assets, focuses on hospitality, multi-family, and industrial real estate, targeting overlooked opportunities.
07-31 03:13
GrabAGun.com Posts On X "BREAKING: AMMO NOW SHIPPING TO CALIFORNIA. The 9th Circuit has ruled California's ammunition restrictions unconstitutional—and we're proud to announce that GrabAGun is now shipping ammo directly to California customers. California is home to one of the largest communities of law-abiding gun owners in the country. This is a major win for the Second Amendment and for freedom-loving Americans across the state. Freedom is back on your doorstep."
https://x.com/grabagun/status/1948770295357038784
07-25 23:54
Renovaro Biosciences Announces Publication Of Peer-Reviewed Study In Vaccines; Says Preclinical Data Validate Renovaro's Platform Representing Step Forward In Fight Against Pancreatic And Solid Tumors
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumorsLOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro Biosciences
07-17 21:20
Novartis Gets Swiss Approval For First Malaria Drug For Babies
Novartis' Coartem Baby wins Swiss approval as the first malaria drug for newborns under 5 kg, offering safer dosing and easier administration.
07-08 19:57
Ainos Announces 5-Yr Distribution Partnership With Solomon Technology To Fast-Track Ainos' AI Nose Platform Into Asia's Key Manufacturing Sectors
AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and MoreSAN DIEGO, CALIFORNIA /
07-07 20:07
【爱建医药】关注BD出海催化和商保支付增量
（转自：爱建证券研究所） 关注BD出海催化和商保支付增量 -爱建生物医药行业周报- 本报告发布于2025年06月30日 投资要点： 医药板块...
07-01 09:13
迈威生物双BD“回血”5.6亿元，核心管线商业化是胜负手
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 在资金链持续紧绷的当口，迈威生物（688062.SH）终于迎来了喘息之机。...
06-30 12:03
迈威生物：与CALICO LIFE SCIENCES LLC签署独家许可协议
6月27日，迈威生物（688062）公告称，公司与CALICO LIFE SCIENCES LLC.拟就IL-11靶向治疗（包括9MW3811）签署《独家许可协议》。根据许可协议，迈威生物独家许可CALICO在除大中华区以外的所有区域内独家开发、生产和商业化许可产品的权利。公司可获得首付款及里程碑付款，以及按许可产品净销售额计算的阶梯式特许权使用费。
06-27 09:57
6月27日操盘必读：影响股市利好或利空消息
专题：下半年A股机会大于风险 内生性盈利底最早有望三季度出现 影响股市利好与利空消息 宏观新闻 1、国务院办公厅日前印发《关于进一...
06-27 08:37
